The major goal of our research is the development of synthetically useful selective biotransformations using microbial enzymes by combining natural and non-natural conditions. Biotransformations to be used in pharmaceutical manufacturing has been studied. Examples from our work will be presented with regards to these strategies, including different applications: ➢ Selective modification (deacylation and demannosilation) of lipoglycopeptide antibiotics by using hydrolases from actinomycetes. Case study: modification of ramoplanin ➢ Chemo- and enantioselective oxidations for the production of optically pure intermediates to be used for the synthesis of different drugs. Case study: chemoenzymatic synthesis of Captopril® Different techniques have been exploited for improving the selectivity and/or productivity of the bioprocesses: reaction engineering, biocatalyst manipulation and reactor engineering.

Biocatalysis for the manufacture of pharma intermediates / F. Molinari. ((Intervento presentato al convegno Chimica Organica e Biotecnologie: Sfide e Opportunità tenutosi a Forte dei Marmi nel 2009.

Biocatalysis for the manufacture of pharma intermediates

F. Molinari
Primo
2009

Abstract

The major goal of our research is the development of synthetically useful selective biotransformations using microbial enzymes by combining natural and non-natural conditions. Biotransformations to be used in pharmaceutical manufacturing has been studied. Examples from our work will be presented with regards to these strategies, including different applications: ➢ Selective modification (deacylation and demannosilation) of lipoglycopeptide antibiotics by using hydrolases from actinomycetes. Case study: modification of ramoplanin ➢ Chemo- and enantioselective oxidations for the production of optically pure intermediates to be used for the synthesis of different drugs. Case study: chemoenzymatic synthesis of Captopril® Different techniques have been exploited for improving the selectivity and/or productivity of the bioprocesses: reaction engineering, biocatalyst manipulation and reactor engineering.
2009
Settore CHIM/11 - Chimica e Biotecnologia delle Fermentazioni
Biocatalysis for the manufacture of pharma intermediates / F. Molinari. ((Intervento presentato al convegno Chimica Organica e Biotecnologie: Sfide e Opportunità tenutosi a Forte dei Marmi nel 2009.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/193117
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact